A.R.T. Advisors’s InflaRx IFRX Stock Holding History

A.R.T. Advisors’s Portfolio IFRX Stock Details IFRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-13,790	Closed	-$34K	–	1506
2019 Q3	$34K	Sell	13,790 -15,372	-53%	-$44.7K	﹤0.01%	1344
2019 Q2	$92K	Buy	29,162 +17,300	+146%	+$547K	0.01%	1205
2019 Q1	$448K	Buy	+11,862	New	+$442K	0.03%	783

Other funds holding IFRX

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

IBT

International Biotechnology Trust London, United Kingdom $297M AUM 17.25% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

A.R.T. Advisors's IFRX Position: Q4 2019 in Review

A.R.T. Advisors sold out of InflaRx (IFRX) in Q4 2019, closing a stake of 13,790 shares — an estimated $34K sold.

A.R.T. Advisors first reported a position in IFRX in Q1 2019 and held it in 3 quarters. The position peaked at $448K in Q1 2019. 20 funds tracked by Wall St. Rank hold IFRX as of Q4 2019.

A.R.T. Advisors reported no remaining InflaRx position as of Q4 2019 after selling out during the quarter.
A.R.T. Advisors sold 13,790 InflaRx shares in Q4 2019, an estimated $34K.
A.R.T. Advisors first reported a position in InflaRx in Q1 2019 and held it in 3 quarters.
A.R.T. Advisors's InflaRx position peaked at $448K in Q1 2019.
20 funds tracked by Wall St. Rank held InflaRx as of Q4 2019.

Based on A.R.T. Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.